Traders should expect reduced liquidity and information asymmetry as Sigyn ceases SEC reporting. The stock will likely trade on the OTC Pink Sheets with minimal disclosure. Monitor for any subsequent going-private transaction or bankruptcy filing, as the cross-filing actuarial verdicts show amplified impact when combined with bankruptcy or going-private contexts.
Price Chart
Executive Summary
Sigyn Therapeutics filed a Form 15-12G to terminate its SEC registration under Section 12(g) and suspend its duty to file reports. The company has only 120 holders of record, which is below the threshold requiring SEC reporting, and is effectively 'going dark' by deregistering its common stock. This is a significant bearish event for existing shareholders as they lose transparency and liquidity, with the stock likely moving to the OTC markets.
Key Facts
- Filed Form 15-12G to terminate registration under Section 12(g) of the Securities Exchange Act of 1934.
- Approximately 120 holders of record as of the certification date.
- Common stock, $0.0001 par value, is the sole class of securities covered.
- No other classes of securities remain subject to reporting under Section 13(a) or 15(d).
- Filed on July 15, 2026, with effectiveness on July 16, 2026.
- CEO James A. Joyce signed the filing.
- Company is incorporated in Delaware with SIC code 3841 (Surgical & Medical Instruments & Apparatus).
- Stock trades on OTC exchange (not a national exchange).
Financial Impact
No financial figures provided; deregistration eliminates SEC reporting obligations for a company with only 120 holders of record.
Risk Factors
- Loss of SEC oversight and transparency for shareholders.
- Potential delisting or further reduced liquidity on OTC markets.
- Possible financial distress or going-private transaction given the low shareholder count and deregistration.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001493152-26-033421 |
| Document: 0001493152-26-033421-index-headers.html | 0001493152-26-033421 |
| Document: 0001493152-26-033421-index.html | 0001493152-26-033421 |
| Document: 0001493152-26-033421.txt | 0001493152-26-033421 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers